Cargando…
Radionuclides: medicinal products or rather starting materials?
The EU directive 2001/83 describes the community code for medicinal products for human use including radiopharmaceuticals. In its current definition, also radionuclide precursors, such as fluorine-18, need to hold a marketing authorization before being placed on the market. The potential of novel ra...
Autores principales: | Neels, Oliver, Patt, Marianne, Decristoforo, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702255/ https://www.ncbi.nlm.nih.gov/pubmed/31659572 http://dx.doi.org/10.1186/s41181-019-0074-3 |
Ejemplares similares
-
Emerging Radionuclides in a Regulatory Framework for Medicinal Products – How Do They Fit?
por: Decristoforo, Clemens, et al.
Publicado: (2021) -
Position paper on requirements for
toxicological studies in the specific case of radiopharmaceuticals
por: Koziorowski, J., et al.
Publicado: (2016) -
Allergens in veterinary medicine
por: Mueller, R. S., et al.
Publicado: (2015) -
Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany
por: Brehler, Randolf, et al.
Publicado: (2016) -
Are we “preparing” radiopharmaceuticals?
por: Decristoforo, Clemens, et al.
Publicado: (2016)